Your browser doesn't support javascript.
loading
Preclinical evaluation of intravenous NAX 810-2, a novel GalR2-preferring analog, for anticonvulsant efficacy and pharmacokinetics.
Metcalf, Cameron S; Klein, Brian D; McDougle, Daniel R; Zhang, Liuyin; Kaufmann, Dan; Bulaj, Grzegorz; White, H Steve.
Afiliação
  • Metcalf CS; Department of Pharmacology & Toxicology, College of Pharmacy, University of Utah, Salt Lake City, Utah, U.S.A.
  • Klein BD; NeuroAdjuvants, Inc., Salt Lake City, Utah, U.S.A.
  • McDougle DR; Department of Pharmacology & Toxicology, College of Pharmacy, University of Utah, Salt Lake City, Utah, U.S.A.
  • Zhang L; NeuroAdjuvants, Inc., Salt Lake City, Utah, U.S.A.
  • Kaufmann D; NeuroAdjuvants, Inc., Salt Lake City, Utah, U.S.A.
  • Bulaj G; Department of Medicinal Chemistry, College of Pharmacy, University of Utah, Salt Lake City, Utah, U.S.A.
  • White HS; Department of Neurology, University of Utah Health Sciences Center, Salt Lake City, Utah, U.S.A.
Epilepsia ; 58(2): 239-246, 2017 02.
Article em En | MEDLINE | ID: mdl-28098336
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Convulsões / Receptor Tipo 2 de Galanina / Avaliação Pré-Clínica de Medicamentos / Anticonvulsivantes Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Convulsões / Receptor Tipo 2 de Galanina / Avaliação Pré-Clínica de Medicamentos / Anticonvulsivantes Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article